Saturday, 14 March 2026

Week 552 Review - Massive losses across the whole portfolio.

One of the worst weeks ever. The deficit between cost and value widened by £11,347 to £144,625 and the deficit between injection and value increased to £54,813. Portfolio value fell to £127,155.

There's no point trying to describe why each share fell, as it was all caused by America and Israel bombing Iran. I'll just catalogue the losses.

Having said that, PAGE:Pagegroup delivered rather rubbish results, so they dropped 17% to go 70% down.

JLP:Jubilee Metals dropped an incredible 14% and I have no clue why.

EDV:Endeavour Mining was the biggest gold miner drop, falling 13%.

ATYM:Atalya Mining and PAF:Pan African Resources both fell 12%.

OPTI:Optibiotix fell 11% and greatly contributed to the losses.

MGNS:Morgan Sindall Group fell 10%.

GGP:Greatland Resources and SOI:Schroder Oriental Income both fell 9%.

FNX:Fonix, III:3i Group, IPX:Impax Asset Management and RIO:Rio Tinto fell 8%.

AMP:Ampeak Energy, AMRQ:Amaroq, ASHM:Ashmore Group, PRU:Prudential and W7L:Warpaint London fell 7%.

CORE:Solidcore Resources and N91:Ninety One fell 6%.

DXRX:Diaceutics, ESTC:Eurpoean Smaller Companies Trust, RAT:Rathbones and RSW:Renishaw fell 5%.

There was a tiny glimmer of positivity.

CKN:Clarkson climbed 5% as they specialise in shipping logistics which may come in handy soon.

KNOS:Kainos Group climbed 8% for no obvious reason, other than the recent fall was way overdone.

MSI:MS International is a defence contractor, so no surprise they climbed 13% and went into profit.

Share of the Week is SBTX:SkinBioTherapeutics which climbed another 34% even after last week's massive rise.

Here's the ISA and shares portfolio after week 32 of year 11.

Weekly Change
Cash£115.91    +£8.89
Portfolio cost£116,389.29-£1,002.31
Portfolio sell value
(bid price-commission)
£36,163.81(-68.9%)-£3,795.04
Potential profits£455.12-£124.56
Yr 11 Dividends£69.36
+£0
Yr 11 Interest£0.85            +£0
Yr 11 Profit from sales£873.14-£193.36
Yr 11 proj avg monthly profit£120.27(1.7%)-£30.91
Total Dividends£12,557.43+£0
Total Interest£9.42    +£0
Total Profit from sales£18,433.41-£193.36
Average monthly cash profit£238.48(3.3%)-£1.95
(Sold stocks profit + Dividends
- Fees / Months)

CAML:Central Asia Metals released an update on the SASA mineral reserves and it wasn't good. SASA has been a complete disaster since they bought it, and their copper operation is near end of life. The CEO that made this one of my favourite companies retired a while ago and I have lost faith in the company. I decided to sell all my holdings immediately, and good job I did, as the share price plummeted all day.

In my AJ Bell dealing account I sold my 365 shares at 223p and made a £193.36 (19.2%) loss, although if you include dividends it was only a 1% loss. On selling the shares I pulled out £800 from my dealing account to go towards my holiday so the injection amount has reduced.

Sell value dropped a big £3,795, but that was a lot better than my SIPP.

Year 11 performance took a bit of a hit due to the realised loss.


Almost back to the lowest of lows.


Right back on the descending trend line.


This chart has always been a bit sad  and is sadder now than it was last week.

The SIPP looks like this after week 536 overall and week 16 of year 11.




Weekly Change
Cash£1,039.31
-£41.19
Portfolio cost£154,237.10
+£1,795.01
Portfolio sell value
(bid price - commission)
£89,836.66(-41.8%)-£8,554.62
Potential profits£12,514.17
-£5,545.34
Yr 11 Dividends£541.92
+£0
Yr 11 Interest£6.26
+£0
Yr 11 Profit from sales£8,076.47
+£1,753.83
Yr 11 proj avg monthly profit£2,319.26(29.1%)+£352.05
Total Dividends£18,762.12
+£0
Total Interest£26.96
+£0
Total Profit from sales£32,742.98
+£1,753.83
Average monthly cash profit£403.01(5.1%)+£13.45   

Not a happy set of figures, although I did take out £1,753 of profits. Some of those were selling CAML:Central Asia Metals. I sold my 1,500 shares at 224.4p and made £907.71 (36.9%) profit. I also top-sliced a few more PAF:Pan African Resources, selling 550 shares at 186.7842p to make £846.12 (466.9%) profit.

I wanted to move some of my PAF holding into something I thought had more chance for a significant rise, so bought another 1,176 shares in THX:Thor Explorations at 89.7p costing £1,061.82. I bought a further 1,241 with some of my CAML proceeds at 88.6p costing £1,106.48. That takes my total holding to 5,401 shares at an average price of 86.3p costing £4,694. They are down 6% altogether.

Although I was initially planning to keep all my CAML proceeds in metals, I decided to use the rest to buy other magic formula shares. I bought 26 shares in RSW:Renishaw at 4152p costing £1,091.87. They are 30th in my magic formula ranking, with very low debt and excellent 5-year growth. ROI and dividend were a bit more middling.

I also bought 1,612 shares in BPCR:BioPharma Credit at 71.1995p costing £1,160.43. They are 32nd in my magic formula ranking, with a superb dividend and no debt, but middling ROI and 5-year growth.

Portfolio value was battered, dropping £8,554, and £5,545 of that was potential profits, as all my most profitable shares dropped and many went out of profit into loss. The sale did raise my long term profits above 5% though, which is excellent.


Such a brief excursion above the injection line.


Below the trend line and almost back down to the worst ever position. Just as it looked like things were turning around.


One crumb of comfort among the misery.

I'm a wee late writing this after going to the Lake District, so nothing more to say other than steeling myself for another depressing write-up.

No comments:

Post a Comment